These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1360506)
21. Synthesis and SAR of novel di- and trisubstituted 1,4-dihydroquinoxaline-2,3-diones related to licostinel (Acea 1021) as NMDA/glycine site antagonists. Zhou ZL; Kher SM; Cai SX; Whittemore ER; Espitia SA; Hawkinson JE; Tran M; Woodward RM; Weber E; Keana JF Bioorg Med Chem; 2003 Apr; 11(8):1769-80. PubMed ID: 12659763 [TBL] [Abstract][Full Text] [Related]
22. Thiokynurenates: a new group of antagonists of the glycine modulatory site of the NMDA receptor. Moroni F; Alesiani M; Galli A; Mori F; Pecorari R; Carlà V; Cherici G; Pellicciari R Eur J Pharmacol; 1991 Jun; 199(2):227-32. PubMed ID: 1720099 [TBL] [Abstract][Full Text] [Related]
23. Characterisation of the binding of [3H]MDL 105,519, a radiolabelled antagonist for the N-methyl-D-aspartate-associated glycine site, to pig cortical brain membranes. Höfner G; Wanner KT Neurosci Lett; 1997 Apr; 226(2):79-82. PubMed ID: 9159494 [TBL] [Abstract][Full Text] [Related]
24. Use of [3H]5,7 dichlorokynurenic acid to identify strychnine-insensitive glycine receptors in human postmortem brain. Wamsley JK; Sofia RD; Faull RL; Ary T; Narang N; McCabe RT Brain Res Bull; 1994; 35(3):205-9. PubMed ID: 7812798 [TBL] [Abstract][Full Text] [Related]
25. The pharmacological specificity of N-methyl-D-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements. Grimwood S; Foster AC; Kemp JA Br J Pharmacol; 1991 Jun; 103(2):1385-92. PubMed ID: 1832067 [TBL] [Abstract][Full Text] [Related]
26. [3H]CGP 61594, the first photoaffinity ligand for the glycine site of NMDA receptors. Benke D; Honer M; Heckendorn R; Pozza MF; Allgeier H; Angst C; Mohler H Neuropharmacology; 1999 Feb; 38(2):233-42. PubMed ID: 10218864 [TBL] [Abstract][Full Text] [Related]
27. Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653. Oblin A; Schoemaker H Eur J Pharmacol; 1994 Jan; 266(1):103-6. PubMed ID: 7907987 [TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro. Boireau A; Malgouris C; Burgevin MC; Pény C; Durand G; Bordier F; Meunier M; Miquet JM; Daniel M; Chevet T; Jimonet P; Mignani S; Blanchard JC; Doble A Eur J Pharmacol; 1996 Apr; 300(3):237-46. PubMed ID: 8739214 [TBL] [Abstract][Full Text] [Related]
29. Felbamate increases [3H]glycine binding in rat brain and sections of human postmortem brain. McCabe RT; Sofia RD; Layer RT; Leiner KA; Faull RL; Narang N; Wamsley JK J Pharmacol Exp Ther; 1998 Aug; 286(2):991-9. PubMed ID: 9694960 [TBL] [Abstract][Full Text] [Related]
30. Calcium antagonists in the olfactory bulbectomy animal model of depression: effect on the cortical NMDA receptor complex. Nowak G Pol J Pharmacol; 1996; 48(2):137-43. PubMed ID: 9112643 [TBL] [Abstract][Full Text] [Related]
32. A novel series of 2-carboxytetrahydroquinolines provides new insights into the eastern region of glycine site NMDA antagonists. Dannhardt G; von Gruchalla M; Kohl BK; Parsons CG Arch Pharm (Weinheim); 2000 Aug; 333(8):267-74. PubMed ID: 11008377 [TBL] [Abstract][Full Text] [Related]
33. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression. Harkin A; Nally R; Kelly JP; Leonard BE J Neural Transm (Vienna); 2000; 107(10):1213-27. PubMed ID: 11129111 [TBL] [Abstract][Full Text] [Related]
34. Regionally distinct stoichiometry for N-methyl-D-aspartate receptor domains in brain. Matsunaga T; Mukhin AG; London ED Neuroreport; 1996 Feb; 7(3):833-7. PubMed ID: 8733756 [TBL] [Abstract][Full Text] [Related]
35. Specific glutathione binding sites in pig cerebral cortical synaptic membranes. Janáky R; Shaw CA; Varga V; Hermann A; Dohovics R; Saransaari P; Oja SS Neuroscience; 2000; 95(2):617-24. PubMed ID: 10658641 [TBL] [Abstract][Full Text] [Related]
36. Interaction of thiokynurenates with the glycine site regulating N-methyl-D-aspartate (NMDA) receptors in rat cortical membranes. Mori F; Alesiani M; Lucherini M; Gori I; Pecorari R; Galli A Pharmacol Res; 1992; 25 Suppl 1():33-4. PubMed ID: 1387212 [No Abstract] [Full Text] [Related]
37. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites. Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653 [TBL] [Abstract][Full Text] [Related]
38. 5,7-Dichlorokynurenic acid, a potent and selective competitive antagonist of the glycine site on NMDA receptors. McNamara D; Smith EC; Calligaro DO; O'Malley PJ; McQuaid LA; Dingledine R Neurosci Lett; 1990 Nov; 120(1):17-20. PubMed ID: 2149877 [TBL] [Abstract][Full Text] [Related]
39. A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. Kessler M; Terramani T; Lynch G; Baudry M J Neurochem; 1989 Apr; 52(4):1319-28. PubMed ID: 2538568 [TBL] [Abstract][Full Text] [Related]
40. Characterization of [3H]thiocolchicoside binding sites in rat spinal cord and cerebral cortex. Balduini W; Cimino M; Depoortere H; Cattabeni F Eur J Pharmacol; 1999 Jul; 376(1-2):149-57. PubMed ID: 10440100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]